Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Quoin Pharmaceuticals logo — Rare Diseases are only rare if you don't live with one.

Quoin Pharmaceuticals

Rare Diseases are only rare if you don't live with one.

Founded 2018 United States Ashburn, United States 5 employees Post Ipo Equity Total: $13.69M Biotechnology, Pharmaceutical

General Information

Company Name Quoin Pharmaceuticals
Founded Year 2018
Location United States Ashburn, United States +1
Employees 5
Industries Biotechnology, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when Quoin Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Quoin Pharmaceuticals

Quoin Pharmaceuticals, founded in 2018, is an emerging specialty pharmaceutical company with a focus on developing and commercializing therapeutic products for rare and orphan diseases. The company's innovative pipeline comprises three products that have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others. Quoin Pharmaceuticals aims to establish a sales infrastructure to commercialize its products in both the U.S. and Europe and seeks to enter into strategic licensing partnerships for all other territories. The company is committed to addressing unmet medical needs for patients, their families, communities, and care teams. Quoin Pharmaceuticals has received a $6.50M Post-IPO Equity investment on 05 March 2024. The company's dedication to finding unique solutions for rare and orphan indications and its commitment to expanding the pipeline of products to address the unmet needs of underserved patient populations make it a compelling prospect for potential investors. To learn more about Quoin Pharmaceuticals, visit their website at www.quoinpharma.com. This company, operating in the Biotechnology and Pharmaceutical industries, is positioning itself as an important player in addressing unmet medical needs in rare disease treatment.

Taxonomy: Rare Diseases, Orphan Diseases, Specialty Pharmaceutical Company, Therapeutic Products, Unmet Medical Needs, Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, Pipeline Development, Sales Infrastructure, Licensing Partnerships, Underserved Patient Populations, Chronic Rare Skin Diseases, Strategic Partnerships

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 05 Mar 2024
Post-IPO Equity •••••• - 22 Feb 2023
Post-IPO Equity •••••• - 30 Aug 2022

Quoin Pharmaceuticals Alternatives & Competitors

Quoin Pharmaceuticals vs
Versantis
Versantis Switzerland

Multiorgan support for rare pediatric and acute liver diseases

Grant
2 employees
Health Care, Health and Wellness
Quoin Pharmaceuticals vs
Seelos Therapeutics, Inc.
Seelos Therapeutics, Inc. United States

A clinical-stage biopharmaceutical company focused on central nervous system disorders and rare dise...

Post Ipo Equity
8 employees
Biotechnology, Pharmaceutical
Quoin Pharmaceuticals vs
Acer Therapeutics Inc.
Acer Therapeutics Inc. United States

Focused on the acquisition, development & commercialization of therapies for serious rare and life-t...

Post Ipo Debt
16 employees
Biotechnology, Health and Wellness

FAQ About Quoin Pharmaceuticals

Rare Diseases are only rare if you don't live with one.
Quoin Pharmaceuticals was founded in 2018.
Quoin Pharmaceuticals is headquartered in Ashburn, United States.
Quoin Pharmaceuticals operates in the following industries: Biotechnology, Pharmaceutical.
Quoin Pharmaceuticals has approximately 5 employees.
Quoin Pharmaceuticals has completed 3 funding rounds, raising a total of $13.69M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Quoin Pharmaceuticals include Versantis, Seelos Therapeutics, Inc., Acer Therapeutics Inc., MILLENDO THERAPEUTICS, Aceragen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Quoin Pharmaceuticals and Versantis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Quoin Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy